Figure 5
From: Baicalin target protein, Annexin A2, is a target of new antitumor drugs
Effect of 0, 10, 25, 50, and 75 μM baicalin treatment on caspase-3 activity in control cells with control siRNA (a) and ANXA2 knockdown HepG2 cells with ANXA2 knockdown siRNA (b). (c) Shows these results on the same coordinate. Three independent experiments were performed, and the data are shown as the mean ± SD. Statistical analyses were performed by one-way ANOVA.
